Matthew Plunkett Insider Trading $CTIC CTI BIOPHARMA CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew Plunkett.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew Plunkett. Matthew Plunkett is EVP, Chief Business Officer in CTI BIOPHARMA CORP ($CTIC) and EVP, Corporate Development in CTI BIOPHARMA CORP ($CTIC) and Chief Financial Officer in Nkarta, Inc. ($NKTX).

Matthew Plunkett in CTI BIOPHARMA CORP

Trading Symbol: CTIC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew Plunkett: EVP, Chief Business Officer, EVP, Corporate Development
Holdings: 526,210 shares
Current Value: $2,457,401
Latest Transaction: Mar 06 2017
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Matthew Plunkett in CTI BIOPHARMA CORP

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CTIC, NKTX

Page: 1 2 3 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 06 2017	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Option Exercise	A	4.33	60,000	259,800	60,000
Mar 23 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Payment of Exercise	F	0.55	63,874	35,016	526,210	590.1 K to 526.2 K (-10.82 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.60	900	536	590,084	591 K to 590.1 K (-0.15 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.60	1,220	726	590,984	592.2 K to 591 K (-0.21 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.59	500	297	592,204	592.7 K to 592.2 K (-0.08 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.59	1,100	652	592,704	593.8 K to 592.7 K (-0.19 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.59	200	118	593,804	594 K to 593.8 K (-0.03 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.59	700	414	594,004	594.7 K to 594 K (-0.12 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.59	700	413	594,704	595.4 K to 594.7 K (-0.12 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.59	844	497	595,404	596.2 K to 595.4 K (-0.14 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.59	1,500	882	596,248	597.7 K to 596.2 K (-0.25 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.59	636	373	597,748	598.4 K to 597.7 K (-0.11 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.59	400	234	598,384	598.8 K to 598.4 K (-0.07 %)
Mar 04 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	0.59	1,300	761	598,784	600.1 K to 598.8 K (-0.22 %)
Feb 05 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.18	300	353	600,084	600.4 K to 600.1 K (-0.05 %)
Feb 05 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.17	700	819	600,384	601.1 K to 600.4 K (-0.12 %)
Feb 05 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.16	600	696	601,084	601.7 K to 601.1 K (-0.10 %)
Feb 05 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.16	3,000	3,465	601,684	604.7 K to 601.7 K (-0.50 %)
Feb 05 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.15	5,000	5,750	604,684	609.7 K to 604.7 K (-0.82 %)
Feb 05 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.14	400	456	609,684	610.1 K to 609.7 K (-0.07 %)
Jan 06 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.26	200	252	610,084	610.3 K to 610.1 K (-0.03 %)
Jan 06 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.25	600	750	610,284	610.9 K to 610.3 K (-0.10 %)
Jan 06 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.24	202	250	610,884	611.1 K to 610.9 K (-0.03 %)
Jan 06 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.24	300	371	611,086	611.4 K to 611.1 K (-0.05 %)
Jan 06 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.23	800	984	611,386	612.2 K to 611.4 K (-0.13 %)
Jan 06 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.22	1,700	2,074	612,186	613.9 K to 612.2 K (-0.28 %)
Jan 06 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.21	1,900	2,299	613,886	615.8 K to 613.9 K (-0.31 %)
Jan 06 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.21	800	964	615,786	616.6 K to 615.8 K (-0.13 %)
Jan 06 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.20	1,898	2,278	616,586	618.5 K to 616.6 K (-0.31 %)
Jan 06 2016	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Sell	S	1.20	1,600	1,912	618,484	620.1 K to 618.5 K (-0.26 %)
Dec 23 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Option Exercise	A	1.24	1,400,000	1,736,000	1,400,000
Dec 23 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Chief Business ...	Option Exercise	D	0.00	253,438	0	0
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.01	200	202	620,084	620.3 K to 620.1 K (-0.03 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.01	100	101	620,284	620.4 K to 620.3 K (-0.02 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.00	4,500	4,500	620,384	624.9 K to 620.4 K (-0.72 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.00	100	100	624,884	625 K to 624.9 K (-0.02 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.00	200	200	624,984	625.2 K to 625 K (-0.03 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.00	300	300	625,184	625.5 K to 625.2 K (-0.05 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.00	100	100	625,484	625.6 K to 625.5 K (-0.02 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.00	100	100	625,584	625.7 K to 625.6 K (-0.02 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.00	600	597	625,684	626.3 K to 625.7 K (-0.10 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	0.99	200	199	626,284	626.5 K to 626.3 K (-0.03 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	0.99	1,100	1,094	626,484	627.6 K to 626.5 K (-0.18 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	0.99	200	199	627,584	627.8 K to 627.6 K (-0.03 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	0.99	200	198	627,784	628 K to 627.8 K (-0.03 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	0.99	600	594	627,984	628.6 K to 628 K (-0.10 %)
Dec 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	0.99	1,500	1,485	628,584	630.1 K to 628.6 K (-0.24 %)
Nov 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.40	1,400	1,960	630,084	631.5 K to 630.1 K (-0.22 %)
Nov 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.40	100	140	631,484	631.6 K to 631.5 K (-0.02 %)
Nov 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.39	1,100	1,529	631,584	632.7 K to 631.6 K (-0.17 %)
Nov 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.39	200	277	632,684	632.9 K to 632.7 K (-0.03 %)
Nov 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.38	3,500	4,830	632,884	636.4 K to 632.9 K (-0.55 %)
Nov 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.38	1,800	2,475	636,384	638.2 K to 636.4 K (-0.28 %)
Nov 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.37	1,900	2,603	638,184	640.1 K to 638.2 K (-0.30 %)
Oct 07 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.53	584	894	640,084	640.7 K to 640.1 K (-0.09 %)
Oct 07 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.53	1,100	1,678	640,668	641.8 K to 640.7 K (-0.17 %)
Oct 07 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.52	6,916	10,512	641,768	648.7 K to 641.8 K (-1.07 %)
Oct 07 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.52	1,400	2,121	648,684	650.1 K to 648.7 K (-0.22 %)
Oct 01 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.43	8,394	12,003	650,084	658.5 K to 650.1 K (-1.27 %)
Oct 01 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.43	100	143	658,478	658.6 K to 658.5 K (-0.02 %)
Oct 01 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.42	9,092	12,911	658,578	667.7 K to 658.6 K (-1.36 %)
Oct 01 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.42	5,108	7,244	667,670	672.8 K to 667.7 K (-0.76 %)
Oct 01 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.41	52,306	73,751	672,778	725.1 K to 672.8 K (-7.21 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.61	660	1,063	725,084	725.7 K to 725.1 K (-0.09 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.61	1,390	2,231	725,744	727.1 K to 725.7 K (-0.19 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.60	14,400	23,040	727,134	741.5 K to 727.1 K (-1.94 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.60	1,500	2,393	741,534	743 K to 741.5 K (-0.20 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.59	16,400	26,076	743,034	759.4 K to 743 K (-2.16 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.59	7,000	11,095	759,434	766.4 K to 759.4 K (-0.91 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.58	5,330	8,421	766,434	771.8 K to 766.4 K (-0.69 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.58	1,000	1,575	771,764	772.8 K to 771.8 K (-0.13 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.57	1,700	2,669	772,764	774.5 K to 772.8 K (-0.22 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.56	800	1,248	774,464	775.3 K to 774.5 K (-0.10 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.55	800	1,240	775,264	776.1 K to 775.3 K (-0.10 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.55	600	927	776,064	776.7 K to 776.1 K (-0.08 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.54	289	445	776,664	777 K to 776.7 K (-0.04 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.54	100	154	776,953	777.1 K to 777 K (-0.01 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.53	6,899	10,555	777,053	784 K to 777.1 K (-0.88 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.53	200	306	783,952	784.2 K to 784 K (-0.03 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.53	13,201	20,132	784,152	797.4 K to 784.2 K (-1.66 %)
Sep 25 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.52	3,600	5,472	797,353	801 K to 797.4 K (-0.45 %)
Sep 23 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Grant	A	0.00	151,739	0	800,953	649.2 K to 801 K (+23.37 %)
Sep 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.55	1,800	2,790	649,214	651 K to 649.2 K (-0.28 %)
Sep 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.54	1,000	1,540	651,014	652 K to 651 K (-0.15 %)
Sep 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.54	1,700	2,610	652,014	653.7 K to 652 K (-0.26 %)
Sep 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.53	5,500	8,415	653,714	659.2 K to 653.7 K (-0.83 %)
Sep 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Payment of Exercise	F	1.52	12,526	19,040	659,214	671.7 K to 659.2 K (-1.86 %)
Aug 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.85	100	185	671,740	671.8 K to 671.7 K (-0.01 %)
Aug 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.85	5,000	9,225	671,840	676.8 K to 671.8 K (-0.74 %)
Aug 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.84	4,900	9,016	676,840	681.7 K to 676.8 K (-0.72 %)
Jul 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.98	200	396	681,740	681.9 K to 681.7 K (-0.03 %)
Jul 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.98	2,256	4,456	681,940	684.2 K to 681.9 K (-0.33 %)
Jul 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.97	444	875	684,196	684.6 K to 684.2 K (-0.06 %)
Jul 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.97	700	1,376	684,640	685.3 K to 684.6 K (-0.10 %)
Jul 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.96	1,000	1,960	685,340	686.3 K to 685.3 K (-0.15 %)
Jul 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.95	400	780	686,340	686.7 K to 686.3 K (-0.06 %)
Jul 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.95	1,200	2,334	686,740	687.9 K to 686.7 K (-0.17 %)
Jul 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.93	1,700	3,281	687,940	689.6 K to 687.9 K (-0.25 %)
Jul 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.93	100	193	689,640	689.7 K to 689.6 K (-0.01 %)
Jul 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.93	700	1,348	689,740	690.4 K to 689.7 K (-0.10 %)
Jul 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.92	1,300	2,496	690,440	691.7 K to 690.4 K (-0.19 %)
Jun 05 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.08	100	208	691,740	691.8 K to 691.7 K (-0.01 %)
Jun 05 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.08	200	415	691,840	692 K to 691.8 K (-0.03 %)
Jun 05 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.07	3,700	7,659	692,040	695.7 K to 692 K (-0.53 %)
Jun 05 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.07	100	207	695,740	695.8 K to 695.7 K (-0.01 %)
Jun 05 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.06	2,400	4,944	695,840	698.2 K to 695.8 K (-0.34 %)
Jun 05 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.06	1,000	2,055	698,240	699.2 K to 698.2 K (-0.14 %)
Jun 05 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.05	2,500	5,125	699,240	701.7 K to 699.2 K (-0.36 %)
May 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.87	600	1,119	701,740	702.3 K to 701.7 K (-0.09 %)
May 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.86	3,000	5,580	702,340	705.3 K to 702.3 K (-0.43 %)
May 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.86	2,700	5,009	705,340	708 K to 705.3 K (-0.38 %)
May 04 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.85	3,700	6,845	708,040	711.7 K to 708 K (-0.52 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.92	300	576	711,740	712 K to 711.7 K (-0.04 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.92	100	192	712,040	712.1 K to 712 K (-0.01 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.91	1,400	2,674	712,140	713.5 K to 712.1 K (-0.20 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.91	100	191	713,540	713.6 K to 713.5 K (-0.01 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.90	1,600	3,040	713,640	715.2 K to 713.6 K (-0.22 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.90	100	190	715,240	715.3 K to 715.2 K (-0.01 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.89	1,400	2,646	715,340	716.7 K to 715.3 K (-0.20 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.89	2,000	3,770	716,740	718.7 K to 716.7 K (-0.28 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.88	1,900	3,572	718,740	720.6 K to 718.7 K (-0.26 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.88	769	1,442	720,640	721.4 K to 720.6 K (-0.11 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.87	5,300	9,911	721,409	726.7 K to 721.4 K (-0.73 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.87	800	1,492	726,709	727.5 K to 726.7 K (-0.11 %)
Apr 08 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.86	800	1,488	727,509	728.3 K to 727.5 K (-0.11 %)
Mar 24 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.98	2,330	4,613	728,309	730.6 K to 728.3 K (-0.32 %)
Mar 24 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.98	2,216	4,377	730,639	732.9 K to 730.6 K (-0.30 %)
Mar 24 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.97	5,184	10,212	732,855	738 K to 732.9 K (-0.70 %)
Mar 24 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.97	11,700	22,991	738,039	749.7 K to 738 K (-1.56 %)
Mar 24 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.96	28,197	55,266	749,739	777.9 K to 749.7 K (-3.62 %)
Mar 24 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.96	7,903	15,450	777,936	785.8 K to 777.9 K (-1.01 %)
Mar 24 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	1.95	1,600	3,120	785,839	787.4 K to 785.8 K (-0.20 %)
Mar 24 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Payment of Exercise	F	1.94	59,784	115,682	787,439	847.2 K to 787.4 K (-7.06 %)
Mar 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.44	1,100	2,684	847,223	848.3 K to 847.2 K (-0.13 %)
Mar 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.44	200	487	848,323	848.5 K to 848.3 K (-0.02 %)
Mar 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.43	600	1,458	848,523	849.1 K to 848.5 K (-0.07 %)
Mar 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.43	200	485	849,123	849.3 K to 849.1 K (-0.02 %)
Mar 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.42	2,800	6,776	849,323	852.1 K to 849.3 K (-0.33 %)
Mar 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.42	300	725	852,123	852.4 K to 852.1 K (-0.04 %)
Mar 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.41	1,700	4,097	852,423	854.1 K to 852.4 K (-0.20 %)
Mar 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.41	1,000	2,405	854,123	855.1 K to 854.1 K (-0.12 %)
Mar 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.40	1,800	4,320	855,123	856.9 K to 855.1 K (-0.21 %)
Mar 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.40	1,100	2,635	856,923	858 K to 856.9 K (-0.13 %)
Mar 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.39	1,200	2,868	858,023	859.2 K to 858 K (-0.14 %)
Feb 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.26	200	452	859,223	859.4 K to 859.2 K (-0.02 %)
Feb 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.25	600	1,350	859,423	860 K to 859.4 K (-0.07 %)
Feb 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.24	500	1,120	860,023	860.5 K to 860 K (-0.06 %)
Feb 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.24	300	671	860,523	860.8 K to 860.5 K (-0.03 %)
Feb 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.23	1,600	3,568	860,823	862.4 K to 860.8 K (-0.19 %)
Feb 06 2015	CTIC	CTI BIOPHARMA CORP	Plunkett Matthew	EVP, Corporate Deve ...	Sell	S	2.23	800	1,780	862,423	863.2 K to 862.4 K (-0.09 %)

Page: 1 2 3 next >